Fed. Circ. Sides With Merck In Reissued Patent Debate

By Nadia Dreid · March 13, 2025, 8:23 PM EDT

The Federal Circuit isn't buying that a reissued patent was actually "issued" at the time it was originally awarded, dashing generic-drug makers' hopes of breaking pharmaceutical giant Merck's hold on a...

To view the full article, register now.

Documents

Case Information

Case Title

Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc.

Case Number

23-2254

Court

Appellate - Federal Circuit

Nature of Suit

835 Patent - (ANDA) (Fed. Qst.)

Date Filed

August 09, 2023